PERIANAL CANDIDIASIS CAUSED BY CANDIDA ALBICANS
Abstract
Background: Candidiasis or candidosis is an infection caused by fungi of the Candida genus, primarily Candida albicans (C. albicans). Perianal candidiasis is a fungal infection that occurs around the anus. This infection is usually caused by Candida fungi, with the species Candida albicans being the most common cause. However, in recent years, Candida non-albicans (CNAC) has increasingly been identified as a causative agent of candidiasis, including in the perianal area. The uniqueness of perianal candidiasis caused by Candida non-albicans includes: (i) Different patterns of antifungal resistance: CNAC species often have different antifungal resistance patterns compared to Candida albicans, which can complicate treatment selection; (ii) More diverse clinical manifestations: Infections caused by CNAC may exhibit a broader range of clinical manifestations than those caused by Candida albicans, making diagnosis more challenging; and (iii) Different epidemiology: CNAC species distribution may vary depending on geographic location and environment, meaning the incidence patterns of candidiasis caused by CNAC may also differ.
Perianal candidiasis and vulvovaginal candidiasis are two common types of fungal infections, particularly in women. Although both are caused by the same Candida genus, their incidence rates and associated risk factors may differ. Perianal candidiasis is not uncommon, particularly in individuals with risk factors such as diabetes, obesity, prolonged antibiotic use, or weakened immune systems. Symptoms of perianal candidiasis are often nonspecific and can overlap with other skin conditions, leading to delayed diagnosis. Perianal and vulvovaginal candidiasis frequently occur simultaneously. Infection in one area can easily spread to the other, particularly if personal hygiene is not well-maintained.
Objectives: To analyze clinical manifestations, including: identifying the most common and specific symptoms of perianal candidiasis, such as itching, redness, rash, and pain; severity level, which involves assessing the severity of the infection and its impact on the patient’s quality of life; complications, specifically identifying possible complications from the infection, such as spread to other areas or secondary infections; identifying pathogenesis factors and mechanisms of infection, specifically understanding how Candida albicans infects the skin around the anus and causes symptoms; and virulence factors, identifying the factors that make Candida albicans pathogenic and disease-causing.
The case study in this research reports on a 47-year-old woman with perianal candidiasis caused by Candida albicans species.
Benefits: Accurate and faster diagnosis of perianal candidiasis, selection of the most appropriate and effective treatment for each patient, assistance in developing effective preventive strategies to reduce the disease burden, and enriching knowledge of the pathogenesis, epidemiology, and management of perianal candidiasis.
Conclusion: Clinical manifestations, specifically, the most common symptoms are itching, redness, rash, and pain around the anus. However, symptom severity may vary among individuals. Prevention, such as maintaining perianal hygiene, controlling underlying medical conditions, and avoiding unnecessary antibiotic use. Patterns of antimicrobial resistance: some studies may indicate an increase in Candida albicans resistance to certain antifungal medications.
Full Text:
PDFReferences
Janik MP, Heffernan MP. Yeast infections: Candidiasis and tinea (pityriasis) versicolor. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick’s dermatology in general medicine 7th ed .New York: Mc Graw Hill; 2008. p.1882-30.
Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Landes bioscience journals: virulence. 2013; 4: 119-28.
Frey D, Oldfield RJ, Bridger RC. Candidiasis. In: A colour atlas of pathogenic fungi. Jansen pharmaceutica; 1979: 76-7.
Grigoriu D, Delacretaz J. Genital and perigenital candidoses. In: Mycology. Cilag-Chemie no.2; 5-53.
Wolff K, Johnson RA. Candidiasis. Fitzpatrick’s color atlas & synopsis of clinical dermatology 6th ed. Mc graw hill. 2009: 718-23.
Hay RJ, Ashbee HR. In: Burns T, Breathnach S, Cox N, Griffiths C. Rook’s textbook of dermatology 8th ed. Wiley-blackwell; 2010.p. 36.56-70.
Hiller E, Zavrel M, Hauster N et al. Adaptation, adhesion and invasion during interaction of candida albicans with the host - focus on the function of cell wall proteins. Ijmm. 2011;384-9.
Gow NAR, Hube B. Importance of the candida albicans cell wall during commensalism and infection. Current opinion in microbiology. 2012; 15: 1-7.
Tonetti D. Candida albicans as the sole organism cultured from a perirectal abscess. Case report in infectious disease. 2012;1-3.
Anchar JM, Fries BC. Candida infection of the genitourinary tract. Journal clin microbial rev. 2010; 23(2): 253-73.
Roger H, William DW, Feng GJ et al. Role of bacterial lipopolysaccharide in enhancing host immune response to candida albicans. Hindawi publishing corp; 2013: 1-9
Mousavi SA, Khalesi E, Bonjar GH et al. Rapid molecular diagnosis for candida species using PCR-RFLP. Biotechnology 6. 2007; 4: 583-7
Saghrouni F, Abdeljelil JB, Boukadida J, Said MB. Molecular methods for strain typing of candida albicans; a review. Journal of applied microbiology. 2013: 1-10.
Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis systematic review and meta-analysis. J clin microbial. 2011; 49(2): 665-70.
Teanpaisan R, Niyombandith M, Pripatnanant P, Sattayasanskul W. Biotypes, genotypes and ketokonazole susceptibility of candida albicans isolated from a group of Thai AIDS patient. New Microbiologica. 2008; 31: 409-416.
Miranda KC, Araujo CR, Costa CR et al. Antifungal activities of azole agent against the malassezia species. J antimicag. 2007; 29: 281-4.
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.